VivoSphere is a biotechnology company developing 3D tissue-engineered models and products for drug discovery. The 3D tissue-engineered environment provides a more human-like tissue, while the microspheroidal geometry allows the VivoSpheres to support applications in a large-scale or high-throughput manner. VivoSphere was founded in 2022 in the United States and has been striving to develop more translational drug discovery and safety testing models. To learn more about VivoSphere, visit www.vivospheres.com.
VivoSphere LLC
VivoSphere
540 Devall Dr
STE 101-1A02-2
Auburn, AL 36832